via Kagan Institute
Breakthrough by experts supports drug therapy as alternative to surgery
World-leading eye experts have made a breakthrough that could potentially change the way cataracts are treated – with potential for drug therapy to replace surgery.
Cataract is a clouding of the eye lens that develops over time and affects the quality of vision. It is caused by an accumulation of protein in the lens that reduce the transmission of light to the retina. Previous research led by ARU found that cataracts account for almost half of global cases of blindness.
A significantly developed cataract can only currently be treated by a surgical procedure to remove the cloudy lens and insert an artificial replacement.
A team of international scientists, led by Professor Barbara Pierscionek of Anglia Ruskin University (ARU), has published peer-reviewed research that shows the sophisticated optics of the lens develops much earlier in gestation than has previously been thought possible. They also found how a particular protein (aquaporin) responsible for water passage in the lens disrupts the optical development, leading to cataract formation.
The scientists have spent more than a decade conducting the most precise measurements on optics of the lens at SPring-8, the world’s largest and most powerful synchrotron, in Japan.
The synchrotron is a particle accelerator that produces powerful X-rays by accelerating electrons to the speed of light. The X-rays allow measurements to be taken with the highest accuracy yet on optical properties of the eye.
The project team is the first in the world to have measured how the optics in the eye lens develop. Their research was presented earlier this month at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting.
Professor Pierscionek, Deputy Dean (Research and Innovation) for the Faculty of Health, Education, Medicine and Social Care and member of the Medical Technology Research Centre at ARU, said: “Cataracts are one of the main causes of vision loss and blindness worldwide, yet for many people surgery is inaccessible for various reasons.
“Our findings indicate the role of the aquaporin proteins and the crucial importance of this for the lens to work correctly and the eye to see clearly.
“Further research in this area is planned, but this discovery, together with our research on nanotechnologies that indicate drug therapy for cataract is possible, could potentially revolutionise the way cataract is treated, opening up the field for drug-based therapy rather than surgery. This would have exciting implications for public health.”
Original Article: New research may revolutionise cataract treatment
More from: Anglia Ruskin University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cataracts
- AGAINST ALL ODDS: Girl Braves Health Challenges To Shine In Class 10 Board Exam
Hatpipliya (Madhya Pradesh): In a testament to resilience and determination, Deepali Thakur, a student of Hatpipalya Garakhedi School, has emerged victorious despite enduring significant health ...
- Eye-care practice opens in-office surgery clinic for cataracts
Dr. Alla Golovkina-Hynes, who opened Eye Care Physicians and Surgeons in 2011, specializes in cataracts and regularly performs cataract surgeries at the Winchester Medical Center and the Shenandoah ...
- Does Medicare Cover Cataract Surgery in 2024? Exploring Benefits and Eligibility
If you're new to Medicare or making different elections for the coming year, you may be wondering about specific coverage areas. For instance, can Medicare help with eye ...
- The Evolution of Cataract Surgery: The Most Common Eye Procedure in Older Adults
[12] In ancient times, cataracts were treated with a technique called couching, which could only be performed when the lens had become completely opaque, rigid, and heavy to the point that the ...
- Is there an alternative cure for cataracts?
Cataracts (cloudiness in the lens of the eye) is a surprisingly common visual problem: the problem often starts in middle-age, and almost everyone over the age of 65 has some degree of cataract ...
Go deeper with Google Headlines on:
Cataracts
[google_news title=”” keyword=”cataracts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Drug therapy for cataracts
- UPDATE 2-US FDA approves Pfizer's gene therapy for rare bleeding disorder
(Adds price of rival therapy in paragraph 5, expert comment in paragraph 8) By Sriparna Roy April 26 (Reuters) - The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B ...
- Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
In addition, the Company announced preliminary XHANCE net product revenue of $14.9 million for the three months ended March 31, 2024, representing growth of approximately 26% over the first quarter of ...
- Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
Eyenovia announced today results from a Phase IV study of Mydcombi® designed to characterize the lowest deliverable dose for mydriasis (pupil dilation). Mydcombi is the only FDA-approved fixed dose ...
- Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review
This scoping review of randomised controlled trials on artificial intelligence (AI) in clinical practice reveals an expanding interest in AI across clinical specialties and locations. The USA and ...
- Restoring sight is possible now with optogenetics
Several companies are experimenting with optogenetics to create a “bionic eye” that can restore sight in visually impaired people.
Go deeper with Google Headlines on:
Drug therapy for cataracts
[google_news title=”” keyword=”drug therapy for cataracts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]